Sphere Medical Holding (LSE:SPHR) 3-Year Book Growth Rate : -32.80% (As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding 3-Year Book Growth Rate?

Sphere Medical Holding's Book Value per Share for the quarter that ended in Dec. 2016 was £0.04.

During the past 12 months, Sphere Medical Holding's average Book Value per Share Growth Rate was -41.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was -32.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was -29.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 9 years, the highest 3-Year average Book Value per Share Growth Rate of Sphere Medical Holding was 10.90% per year. The lowest was -42.30% per year. And the median was -24.65% per year.

Competitive Comparison of Sphere Medical Holding's 3-Year Book Growth Rate

For the Medical Devices subindustry, Sphere Medical Holding's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sphere Medical Holding's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's 3-Year Book Growth Rate falls into.

Sphere Medical Holding 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Sphere Medical Holding (LSE:SPHR) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Sphere Medical Holding 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.